Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
270.01
+12.76 (4.96%)
At close: Jun 17, 2026, 4:00 PM EDT
270.01
0.00 (0.00%)
After-hours: Jun 17, 2026, 4:10 PM EDT

PRAX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
--8.552.45--
Revenue Growth (YoY)
--249.53%---
Gross Profit
--8.552.45--
Selling, General & Admin
73.0359.0856.3142.0559.9547.08
Research & Development
284.3267.12152.4186.77155.04120.26
Total Operating Expenses
357.33326.2208.72128.82214.99167.33
Operating Income
-357.33-326.2-200.17-126.37-214.99-167.33
Total Non-Operating Income (Expense)
30.822.9317.353.10.960.27
Pretax Income
-326.53-303.27-182.82-123.28-214.03-167.06
Net Income
-326.53-303.27-182.82-123.28-214.03-167.06
Net Income to Common
-326.53-303.27-182.82-123.28-214.03-167.06
Shares Outstanding (Basic)
242318733
Shares Outstanding (Diluted)
242318733
Shares Change (YoY)
24.13%25.68%171.55%114.58%8.58%-
EPS (Basic)
-13.37-13.48-10.21-18.69-69.65-59.10
EPS (Diluted)
-13.37-13.48-10.21-18.69-69.65-59.10
Free Cash Flow
-282.33-249.12-131.76-111.19-185.49-125.6
Free Cash Flow Per Share
-11.55-11.07-7.36-16.86-60.36-44.38
Gross Margin
--100.00%100.00%--
Operating Margin
---2340.29%-5164.41%--
Profit Margin
---2137.48%-5037.88%--
FCF Margin
---1540.48%-4543.77%--
EBITDA
-357.2-326.06-199.81-125.94-214.57-167.15
EBITDA Margin
---2336.10%-5146.75%--
EBIT
-357.33-326.2-200.17-126.37-214.99-167.33
EBIT Margin
---2340.29%-5164.41%--
SEC Filings: 10-K · 10-Q